Astra to challenge Roche in small cell lung cancer - Vantage

Astra to challenge Roche in small cell lung cancer  Vantage

An apparent success in the first-line SCLC Caspian trial could give Imfinzi a new use and allow it to challenge Roche in a setting where Tecentriq secured a US ...



Comments

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Oncology: The disease, dynamics & challenges of market research

Division of Continuing Professional Development